Akoustis Technologies, Inc. (AKTS) Stock
Akoustis Technologies stock price chart
AKTS stock quote & key statistics
Akoustis Technologies annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $6.5M | -$63.7M | -$16.52 |
| FY2024 | $1.5M | -$44.0M | — |
| FY2023 | $27.1M | -$28.6M | -$0.66 |
| FY2022 | $0 | -$17.9M | -$0.69 |
| FY2021 | $15.3M | -$59.2M | -$0.59 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Akoustis Technologies, Inc.
Akoustis Technologies, Inc., operating through its subsidiary Akoustis, Inc., is a leading provider of advanced radio frequency (RF) filter products catering primarily to the mobile wireless device industry across global markets including the United States, Asia, Europe, and beyond. The company operates under two main segments: Foundry Fabrication Services and RF Filters.
Under the Foundry Fabrication Services segment, Akoustis offers comprehensive engineering review services and microelectromechanical systems foundry services, ensuring precise and efficient manufacturing processes for its RF products. These services are integral to maintaining high standards of quality and performance across its product range.
The RF Filters segment is focused on delivering cutting-edge amplifier and filter products designed specifically for a variety of applications. These include RF filters tailored for smartphones, tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and specialized solutions for military and defense sectors. Akoustis Technologies remains committed to advancing RF filter technology to meet the increasing demand for improved wireless connectivity and performance.
Headquartered in Huntersville, North Carolina, Akoustis Technologies continues to innovate and expand its market presence through ongoing research and development efforts. With a strong emphasis on technological excellence and customer satisfaction, the company is well-positioned to address the evolving needs of the mobile wireless industry globally.
Akoustis Technologies stock FAQ
What is the Akoustis Technologies stock ticker symbol?
Akoustis Technologies, Inc. trades on the NASDAQ under the ticker symbol AKTS.
What sector and industry is Akoustis Technologies in?
Akoustis Technologies, Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Akoustis Technologies have?
Akoustis Technologies, Inc. has about 79 full-time employees.
What were Akoustis Technologies's revenue and earnings last fiscal year?
Akoustis Technologies reported revenue of $6.5M and net income of -$63.7M in fiscal 2025, with earnings per share of -$16.52. Revenue grew 336.9% from the prior year.
Is Akoustis Technologies in the Russell 2000?
Yes. Akoustis Technologies, Inc. (AKTS) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Akoustis Technologies go public?
Akoustis Technologies stock began trading on January 9, 2026.
Russell 2000 Biotechnology stocks
All Russell 2000 →- CGONCG Oncology
- COGTCogent Biosciences
- CRSPCRISPR Therapeutics
- CYTKCytokinetics
- DFTXDefinium Therapeutics
- DNTHDianthus Therapeutics
- IBRXImmunityBio
- IOVAIovance Biotherapeutics
- KODKodiak Sciences
- KRYSKrystal Biotech
- KYMRKymera Therapeutics
- LGNDLigand Pharmaceuticals
- MIRMMirum Pharmaceuticals
- ORKAOruka Therapeutics
- PCVXVaxcyte
- PRAXPraxis Precision Medicines
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- RYTMRhythm Pharmaceuticals
- SRRKScholar Rock
- SYRESpyre Therapeutics
- TGTXTG Therapeutics
- TVTXTravere Therapeutics
- TWSTTwist Bioscience